trending Market Intelligence /marketintelligence/en/news-insights/trending/Dm7SjvcuL2D6oOMFjs4xXA2 content esgSubNav
In This List

Maricann Group appoints CFO

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Maricann Group appoints CFO

Maricann Group Inc. appointed Scott Langille as CFO, effective Oct. 2, subject to regulatory approval.

Previously, the company's CEO Ben Ward had taken the additional role of interim CFO.

Langille was formerly CFO of Tribute Pharmaceuticals Canada Inc., which was sold to Pozen Inc. in February 2016 for $160 million to form Aralez Pharmaceuticals Inc.